88 related articles for article (PubMed ID: 11968171)
1. [The angiogenesis inhibitor vasostatin. In tumor inhibiting doses there is no impaired wound healing in the mouse model].
Hautarzt; 2002 Feb; 53(2):154. PubMed ID: 11968171
[No Abstract] [Full Text] [Related]
2. Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin.
Yao L; Pike SE; Pittaluga S; Cherney B; Gupta G; Jaffe ES; Tosato G
Cancer Immunol Immunother; 2002 Sep; 51(7):358-66. PubMed ID: 12192535
[TBL] [Abstract][Full Text] [Related]
3. The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses.
Lange-Asschenfeldt B; Velasco P; Streit M; Hawighorst T; Pike SE; Tosato G; Detmar M
J Invest Dermatol; 2001 Nov; 117(5):1036-41. PubMed ID: 11710910
[TBL] [Abstract][Full Text] [Related]
4. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function.
Yao L; Pike SE; Tosato G
J Leukoc Biol; 2002 Jan; 71(1):47-53. PubMed ID: 11781379
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth.
Pike SE; Yao L; Setsuda J; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Atreya CD; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G
Blood; 1999 Oct; 94(7):2461-8. PubMed ID: 10498619
[TBL] [Abstract][Full Text] [Related]
6. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
Xiao F; Wei Y; Yang L; Zhao X; Tian L; Ding Z; Yuan S; Lou Y; Liu F; Wen Y; Li J; Deng H; Kang B; Mao Y; Lei S; He Q; Su J; Lu Y; Niu T; Hou J; Huang MJ
Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
[TBL] [Abstract][Full Text] [Related]
7. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12.
Yao L; Pike SE; Setsuda J; Parekh J; Gupta G; Raffeld M; Jaffe ES; Tosato G
Blood; 2000 Sep; 96(5):1900-5. PubMed ID: 10961892
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
10. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
[TBL] [Abstract][Full Text] [Related]
11. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth.
Pike SE; Yao L; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G
J Exp Med; 1998 Dec; 188(12):2349-56. PubMed ID: 9858521
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin].
Zhang GF; Wang YH; Zhang MA; Wang Q; Luo YB; Wang DS; Han CR
Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397
[TBL] [Abstract][Full Text] [Related]
13. Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors.
Jazowiecka-Rakus J; Jarosz M; Kozłowska D; Sochanik A; Szala S
Acta Biochim Pol; 2007; 54(1):125-33. PubMed ID: 17369879
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice.
Li L; Yuan YZ; Lu J; Xia L; Zhu Y; Zhang YP; Qiao MM
Gut; 2006 Feb; 55(2):259-65. PubMed ID: 16287901
[TBL] [Abstract][Full Text] [Related]
15. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
Jazowiecka-Rakus J; Jarosz M; Szala S
Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.
Abramson LP; Stellmach V; Doll JA; Cornwell M; Arensman RM; Crawford SE
J Pediatr Surg; 2003 Mar; 38(3):336-42; discussion 336-42. PubMed ID: 12632345
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and surgery: from mice to man.
Drixler TA; Voest EE; van Vroonhoven TJ; Borel Rinkes IH
Eur J Surg; 2000 Jun; 166(6):435-46. PubMed ID: 10890539
[No Abstract] [Full Text] [Related]
18. Inhibition of angiogenesis by Abeta peptides.
Paris D; Townsend K; Quadros A; Humphrey J; Sun J; Brem S; Wotoczek-Obadia M; DelleDonne A; Patel N; Obregon DF; Crescentini R; Abdullah L; Coppola D; Rojiani AM; Crawford F; Sebti SM; Mullan M
Angiogenesis; 2004; 7(1):75-85. PubMed ID: 15302999
[TBL] [Abstract][Full Text] [Related]
19. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
Diao Y; Ma J; Li X; Sun X; Xu R
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
[TBL] [Abstract][Full Text] [Related]
20. [The story of angiostatin and how controversy is useful in science].
Kurjak A
Acta Med Croatica; 2003; 57(2):145-8. PubMed ID: 12879695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
